Yungjin Pharm. Co., Ltd. (KRX:003520)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,979.00
+22.00 (1.12%)
Last updated: Oct 2, 2025, 9:00 AM KST
1.12%
Market Cap361.94B
Revenue (ttm)158.79B
Net Income (ttm)8.53B
Shares Out182.89M
EPS (ttm)53.49
PE Ratio37.00
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume197,724
Average Volume263,380
Open1,975.00
Previous Close1,957.00
Day's Range1,954.00 - 1,982.00
52-Week Range1,823.00 - 2,665.00
Beta0.89
RSI42.26
Earnings Daten/a

About Yungjin Pharm.

Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It offers cephalosporin antibiotic, antipsychotic, cardiovascular, gastrointestinal, metabolic, neuropsychiatry, respiratory, infectious, anti-inflammatory and analgesics, nutritional supplement, and urology products. The company also provides vitamins, minerals, and other products; and APIs. Yungjin Pharm. Co., Ltd. was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. operates as a subsidiary of KT&G Corporation... [Read more]

Sector Healthcare
Founded 1952
Employees 559
Stock Exchange Korea Stock Exchange
Ticker Symbol 003520
Full Company Profile

Financial Performance

In 2012, Yungjin Pharm.'s revenue was 137.69 billion, an increase of 22.82% compared to the previous year's 112.11 billion. Earnings were 1.79 billion, a decrease of -30.48%.

Financial Statements

News

There is no news available yet.